Enovis Corporation (ENOV) USD0.001
Sell:$29.93Buy:$33.32
$0.80
(2.57%)
- This stock can be held in a
Stocks and Shares ISA$0.80
(2.57%)$0.80
(2.57%)Company Information
About this company
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Key people
Key facts
- EPICENOV
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- ISINUS1940145022
- Market cap$1.78bn
- Employees7,367
- Shares in issue57.11m
- ExchangeNew York Stock Exchange
- IndexS&P 600 Small Cap, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.